What's in Laboratoire Innotech International's pipeline?

Laboratoire Innotech International has 5 drugs in our index: 3 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Laboratoire Innotech International's portfolio?

Top competitors by shared drug class: Ache Laboratorios Farmaceuticos S.A., Aesculape CRO Belgium BV, All India Institute of Medical Sciences, AmDerma, Bausch Health Americas, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/laboratoire-innotech-international.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Laboratoire Innotech International — Portfolio Competitive Intelligence Brief

Laboratoire Innotech International pipeline: 3 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Polygynax combinaison of polymyxin, Neomycin and Nystatin	Polygynax combinaison of polymyxin, Neomycin and Nystatin	marketed
TOT'HEMA	TOT'HEMA	marketed	Iron supplement		Hematology
Benzalkonium Chloride Spermicide Cream	Benzalkonium Chloride Spermicide Cream	marketed	Spermicide		Contraception
GYNODAKTARIN®	GYNODAKTARIN®	phase 3	Imidazole antifungal	Lanosterol 14α-demethylase (CYP51)	Dermatology / Infectious Disease
POLYGYNAX®	POLYGYNAX®	phase 3	Combination antibiotic and antifungal agent		Infectious Disease / Gynecology

Therapeutic area mix

Contraception · 1
Dermatology / Infectious Disease · 1
Hematology · 1
Infectious Disease / Gynecology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aesculape CRO Belgium BV · 1 shared drug class
All India Institute of Medical Sciences · 1 shared drug class
AmDerma · 1 shared drug class
Bausch Health Americas, Inc. · 1 shared drug class
Bayer · 1 shared drug class
Cardiochirurgia E.H. · 1 shared drug class
Abdelwahed, Mai Mahmoud Mohamed, M.D. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Laboratoire Innotech International:

Cite this brief

Drug Landscape (2026). Laboratoire Innotech International — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/laboratoire-innotech-international. Accessed 2026-05-16.